# Christine L. Baker

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christine-l-baker/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,934 |
| Field | Smoking Behavior and Cessation |
| h-index | 21 |
| i10-index | 33 |
| Last Known Institution | Pfizer (United States) |
| OpenAlex ID | https://openalex.org/A5040177032 |
| ORCID iD | 0000-0001-7532-7399 |
| Works | 96 |

## Researcher papers

- [Frequency of <i>KRAS</i>, <i>BRAF</i>, and <i>NRAS</i> mutations in colorectal cancer](https://scholariq.org/papers/frequency-of-i-kras-i-i-braf-i-and-i-nras-i-mutations-in-colorectal-cancer/)
- [Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire](https://scholariq.org/papers/confirmatory-factor-analyses-and-reliability-of-the-modified-cigarette/)
- [Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt](https://scholariq.org/papers/effect-of-varenicline-and-bupropion-sr-on-craving-nicotine-withdrawal-symptoms/)
- [Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model](https://scholariq.org/papers/cost-utility-analysis-of-varenicline-versus-existing-smoking-cessation/)
- [Risk assessment of readmissions following an initial COPD-related hospitalization](https://scholariq.org/papers/risk-assessment-of-readmissions-following-an-initial-copd-related/)
- [OESTRADIOL-17α AND PITUITARY RESPONSIVENESS TO LUTEINIZING HORMONE RELEASING FACTOR IN THE RAT: A STUDY USING RECTANGULAR PULSES OF OESTRADIOL-17β MONITORED BY NON-CHROMATOGRAPHIC RADIOIMMUNOASSAY](https://scholariq.org/papers/oestradiol-17-and-pituitary-responsiveness-to-luteinizing-hormone-releasing/)
- [Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale](https://scholariq.org/papers/revealing-the-multidimensional-framework-of-the-minnesota-nicotine-withdrawal/)
- [Benefits of quitting smoking on work productivity and activity impairment in the United States, the European Union and China](https://scholariq.org/papers/benefits-of-quitting-smoking-on-work-productivity-and-activity-impairment-in-the/)
- [The Cost-Effectiveness of an Extended Course (12 + 12 Weeks) of Varenicline Compared with Other Available Smoking Cessation Strategies in the United States: An Extension and Update to the BENESCO Model](https://scholariq.org/papers/the-cost-effectiveness-of-an-extended-course-12-12-weeks-of-varenicline-compared/)
- [Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification](https://scholariq.org/papers/real-world-characterization-and-differentiation-of-the-global-initiative-for/)
- [A Retrospective Study of Clinical and Economic Burden of Focal Segmental Glomerulosclerosis (FSGS) in the United States](https://scholariq.org/papers/a-retrospective-study-of-clinical-and-economic-burden-of-focal-segmental/)
- [Development of a Conceptual Model for the Patient Experience of Immunoglobulin A Nephropathy (IgAN): A Qualitative Literature Review](https://scholariq.org/papers/development-of-a-conceptual-model-for-the-patient-experience-of-immunoglobulin-a/)

## Researcher topics

- [Smoking Behavior and Cessation](https://scholariq.org/topics/smoking-behavior-and-cessation/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Researcher university

- [Pfizer (United States)](https://scholariq.org/institutions/pfizer-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
